Home Twitter Page 3

Twitter

Most popular

The Misleading Marketing of “Low-T” Drugs

Pharma Guy - January 1, 2014

Big Pharma Racks Up Facebook Likes But Not So Much from...

Pharma Guy - January 1, 2014

Maureen Winigrad and John Griffith: The Sudden Unexpected Death in Epilespy...

Pharma Guy - January 1, 2014

Pharmaguy™ Interviews John LaMattina: Devalued and Distrusted

Pharma Guy - January 1, 2014

Patients Speak For and Against Direct-to-Consumer Off-Label Promotion of Drugs

Pharma Guy - January 1, 2014

The Benefits and Risks of Limiting Pharma Sales Rep Access to...

Pharma Guy - January 1, 2014

Emily Sitrin Mason: A Successful, Integrated Mobile App Ad Campaign

Pharma Guy - January 1, 2014

Len Starnes: The Emerging Virtual Medical Conference

Pharma Guy - January 1, 2014

Lea Katsanis: Benefits & Risks of Rx Brand Personality

Pharma Guy - January 1, 2014

Patricia Alves and Jaclyn Fonteyne: TweetChat Return on Investment

Pharma Guy - January 1, 2014

1 234...11 Page 3 of 11

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Stopwatch with pharmaceutical products and analytics dashboard representing speed in pharma marketing

The Velocity Problem: When Pharma Marketing Moves Slower Than the Market

April 17, 2026

Pharmaceutical marketing concept showing hidden stakeholders like policymakers, media, and algorithms influencing healthcare decisions

Invisible Audiences: The Stakeholders Pharma Marketing Ignores at Its Own Risk

April 16, 2026

The Trust Ceiling: Why Some Pharma Brands Can’t Improve Perception—No Matter...

April 16, 2026